Hims & Hers Health Inc
NYSE:HIMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Hims & Hers Health Inc (HIMS) under the Base Case is 34.7536 USD per share.
Compared with the current market price of 19.3325 USD, the stock appears
Undervalued by 44% .
The intrinsic value is calculated using the DCF method. The model assumes revenue growth slows from 33% in 2026 to 14% a year over the next five years; its next three-year pace is 23%, versus 65% over the last three. Net margin recovers from losses to 8% by 2033, below its six-year high.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Hims & Hers Health Does
Hims & Hers Health is a direct-to-consumer telehealth company that connects people with licensed medical providers through its online platform. It sells prescription treatments and wellness products for common health needs such as sexual health, hair loss, skin care, mental health, and weight management, along with related over-the-counter products and subscriptions.
- Headquarters
- United States of America US
- Employees
- 2 442
- IPO date
- Sep 9, 2019
Hims & Hers Health has no economic moat
Customers can obtain similar treatments elsewhere, and moving to another provider generally requires a new medical review rather than a costly change of systems or extensive retraining. Hims & Hers offers convenience and personalized care, but competitors can provide similar online consultations, medications and home delivery.
Read the full moat analysis
Earnings Waterfall
Hims & Hers Health Inc
What is the Intrinsic Value of one HIMS stock?
The intrinsic value for Hims & Hers Health Inc (HIMS) under the Base Case is 34.7536 USD.
Is HIMS stock undervalued or overvalued?
Compared with the current market price of 19.3325 USD, the stock appears Undervalued by 44% .
